PAHC

Phibro Animal Health Corporation Class A Common Stock (PAHC) | Rumor.io

Phibro Animal Health

PAHC

Attention (50-day avg)0%

Attention rank (50-day avg)#3,313

Bullish sentiment (50-day avg)100%

Price to earnings ratio14.2

Market capitalization1.4B

Earnings per share2.43

Dividend yield (TTM)1.34%

Revenue (annual)1.5B

Net income (annual)99.7M

Social

What share of all stock conversation is about PAHC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% 0	0% +0

Feb 28

Insider selling activity has been observed at Phibro Animal Health Corporation, with 3 insiders selling $1.1M worth of shares over 7 days.
The selling activity was identified as a cluster sell, indicating a potential trend of insiders reducing their holdings.
The specific ticker symbol mentioned is $PAHC, referring to Phibro Animal Health Corporation.

Generated by AI

Sentiment

Of the messages about PAHC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	98.26% +1.67
Bearish	—	—	0% 0	1.74% -1.67

Topics

Of the messages about PAHC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	57.14%	2.74%
Announcements	—	—	42.86%	43.14%
Analysts	—	—	0%	6.48%
Controversies	—	—	0%	0%
Macro	—	—	0%	8.98%
Technical Analysis	—	—	0%	38.65%

May 7

Phibro Animal Health Corporation ($PAHC) reported quarterly earnings that beat estimates by $0.02 EPS.
The company's earnings per share (EPS) was $0.46, exceeding the consensus estimate of $0.44.
Revenue for the quarter was $209.00 million.

Generated by AI

Community

Of the messages about PAHC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	75.86%	52.84%
Newcomers	—	0%	24.14%	47.16%

Regulars· Aug 26

Phibro Animal Health Corporation has reported its fourth-quarter and fiscal year results, with guidance provided for its fiscal first quarter.
The company's earnings per share (EPS) missed estimates by $0.05, and revenue also missed expectations.
Phibro Animal Health has filed form 8-K and form 10-K with the SEC, which include its quarterly and annual reports.

Newcomers· Apr 29

Newcomers to Phibro Animal Health Corporation are excited about the company's potential for growth, citing its acquisition of Zoetis' medicated feed additive portfolio as a key factor.
The acquisition of Zoetis' portfolio is seen as a strategic move by Phibro Animal Health to enhance its commitment to animal health, with newcomers noting that both companies are focused on innovation and growth.
The deal's $350 million price tag has caught the attention of newcomers, who are tracking the trend of Phibro Animal Health's stock in relation to the acquisition, with some noting that the stock has trended 28 times in the past 24 hours.

Generated by AI

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

2d agoYahoo Finance

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

4d agoYahoo Finance

Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q2 Earnings?

Shareholders of Phibro Animal Health would probably like to forget the past six months even happened. The stock dropped 38.5% and now trades at $34.11. This may have investors wondering how to approach the situation.

5d agoYahoo Finance

Branded Pharmaceuticals Stocks Q2 In Review: Phibro Animal Health (NASDAQ:PAHC) Vs Peers

7d agofinance.yahoo.com

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference

TEANECK, N.J., September 09, 2026--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference.

20d agoYahoo Finance

Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain?

Phibro Animal Health earnings and guidance set the tone Phibro Animal Health (PAHC) drew investor attention after issuing earnings guidance for the fiscal year ending June 30, 2027, alongside reporting fourth quarter and full year 2026 results. The company now projects 2027 net sales of US$1.55b to US$1.60b and net income of US$122 million to US$132 million. Expected diluted EPS is US$2.98 to US$3.22. These figures follow 2026 sales of US$1,518.09 million and net income of US$99.72...

25d agoYahoo Finance

Also Discussed

Investors talking about PAHC also mention

#	Name	Attention
1	ScanSource, Inc.SCSC	0%0
2	Zoetis Inc. Class A Common StockZTS	0.03%+0.02
3	OMIC - Singular Genomics Systems, Inc.	——
4	Pharvaris N.V. Ordinary SharesPHVS	0%0
5	Phathom Pharmaceuticals, Inc.PHAT	0%new
6	Pacira BioSciences, Inc.PCRX	0%new
7	Praxis Precision Medicines, Inc.PRAX	0%0
8	Pyxis Oncology, Inc. Common StockPYXS	0%0
9	Prestige Consumer Healthcare Inc.PBH	0%0
10	Regenxbio Inc.RGNX	0%+0

Phibro Animal Health Corporation Class A Common Stock

Healthcare
Drug Manufacturers - Specialty & Generic

Phibro Animal Health Corporation Class A Common Stock represents ownership in Phibro Animal Health Corporation, a global animal health and mineral nutrition company. Phibro develops, manufactures, and markets products for food-producing and companion animals, supporting sectors such as poultry, swine, beef and dairy cattle, aquaculture, and pets. Its portfolio spans animal health solutions, mineral nutrition products, and performance products used in livestock production and animal care. The company serves customers across the agricultural and veterinary supply chains, where its offerings help address nutrition, health, and productivity needs in animal operations. Phibro Animal Health Corporation is headquartered in Teaneck, New Jersey, and its Class A common stock is one of the company’s primary publicly traded equity classes.

Website

Location

Glenpointe Centre East

Teaneck, NJ, 07666-6712

United States

Social

What share of all stock conversation is about PAHC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% 0	0% +0

Feb 28

Insider selling activity has been observed at Phibro Animal Health Corporation, with 3 insiders selling $1.1M worth of shares over 7 days.
The selling activity was identified as a cluster sell, indicating a potential trend of insiders reducing their holdings.
The specific ticker symbol mentioned is $PAHC, referring to Phibro Animal Health Corporation.

Generated by AI

Sentiment

Of the messages about PAHC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	98.26% +1.67
Bearish	—	—	0% 0	1.74% -1.67

Topics

Of the messages about PAHC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	57.14%	2.74%
Announcements	—	—	42.86%	43.14%
Analysts	—	—	0%	6.48%
Controversies	—	—	0%	0%
Macro	—	—	0%	8.98%
Technical Analysis	—	—	0%	38.65%

May 7

Phibro Animal Health Corporation ($PAHC) reported quarterly earnings that beat estimates by $0.02 EPS.
The company's earnings per share (EPS) was $0.46, exceeding the consensus estimate of $0.44.
Revenue for the quarter was $209.00 million.

Generated by AI

Community

Of the messages about PAHC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	75.86%	52.84%
Newcomers	—	0%	24.14%	47.16%

Regulars· Aug 26

Phibro Animal Health Corporation has reported its fourth-quarter and fiscal year results, with guidance provided for its fiscal first quarter.
The company's earnings per share (EPS) missed estimates by $0.05, and revenue also missed expectations.
Phibro Animal Health has filed form 8-K and form 10-K with the SEC, which include its quarterly and annual reports.

Newcomers· Apr 29

Newcomers to Phibro Animal Health Corporation are excited about the company's potential for growth, citing its acquisition of Zoetis' medicated feed additive portfolio as a key factor.
The acquisition of Zoetis' portfolio is seen as a strategic move by Phibro Animal Health to enhance its commitment to animal health, with newcomers noting that both companies are focused on innovation and growth.
The deal's $350 million price tag has caught the attention of newcomers, who are tracking the trend of Phibro Animal Health's stock in relation to the acquisition, with some noting that the stock has trended 28 times in the past 24 hours.

Generated by AI

Phibro Animal Health

Social

Feb 28

Sentiment

Topics

May 7

Community

Regulars· Aug 26

Newcomers· Apr 29

News

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q2 Earnings?

Branded Pharmaceuticals Stocks Q2 In Review: Phibro Animal Health (NASDAQ:PAHC) Vs Peers

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference

Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain?

Also Discussed

Phibro Animal Health Corporation Class A Common Stock

Company Information

Location

News

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q2 Earnings?

Branded Pharmaceuticals Stocks Q2 In Review: Phibro Animal Health (NASDAQ:PAHC) Vs Peers

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference

Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain?

Also Discussed

Social

Feb 28

Sentiment

Topics

May 7

Community

Regulars· Aug 26

Newcomers· Apr 29